Webinar | Beyond Taste: Multisensory Trends Driving Food Indulgence
14 August | 12 PM ET: Register Now

Hertz Life Science Technology

Hertz Life Science Technology uses virus-like particle VLPs technology to develop animal and human vaccines.
2020
Shenzhen, Guangdong, China

Investment Funding

Last Funding Stage

Early Stage Venture

Last Funding Date

28-01-2026

Startup Stage

Series A

Lead Investors

Northern Light Venture Capital

About

Hertz Life Science Technology uses virus-like particle VLPs technology to develop animal and human vaccines. The company has several underlying core patented technologies and has established a stable and efficient research and development platform based on the Jiyin Biomedical Transformation (Greater Bay Area) base, and actively promotes the research and development of vaccines. At present, the company has carried out extensive and in-depth cooperation with large enterprises such as Qingdao Yibang and Wen’s Group, and its R&D strength has been highly recognized by peers and upstream and downstream enterprises.

Something missing or incorrect on this page? Help us enrich this information